In mice, intraperitoneal injections of OBCAM-expressing malignant cells resulted in significantly decreased rate of tumorigenesis, decreased development of ascites, and decreased peritoneal extension of ovarian cancer cell lines, compared with controls [39]. This evidence concerns the gene OPCML and ovarian carcinoma.